NOTE: Please grab your lunch and be seated no later than 11:45 AM.

Please join us for a sponsored lunch presentation by Neurocrine Biosciences, Inc.!

The session will provide an introduction to tardive dyskinesia that reviews clinical presentation, risk factors, impact, and regulatory guidelines related to TD. It will also include a discussion on treatment considerations for managing TD in the older adult, such as dosage and administration options as well as safety and efficacy data in special populations.